Pharma Focus Asia

Strategy

A winning strategy is essential to reach or accomplish goals in pharmaceutical industry. However, maintaining the excellence of Strategic Drug Development Services is a necessary stipulation for the Strategic evolution for Pharma companies. The technologies leading to Pharmaceutical regulatory strategy and Pharmaceutical strategic developments are at the limits of human knowledge. The huge size of the companies, organizations and the complexities of their technologies and processes present many challenges. On the other hand, strategy development and distribution system is highly costly to implement. The effective Pharma strategies can help to generate business exposure, relationship building, and market research. Thus, they are important initiatives to boom overall business in the long term.

The JAPAC Drug Development Market

Understanding the regulatory landscape and cultural nuances

Regulatory authorities are critical to the development and commercialisation of drugs as they govern the safety

CELL AND GENE THERAPY (CGT)

Key regulatory insights

CGT stands at the forefront of personalised medicine revolutionising healthcare by modifying patients

Securing Long-term Success

What to look for in a cell culture media supplier

Cell culture media is a significant driver of productivity within biopharmaceutical manufacturing processes

Accelerating Cell and Gene Therapy Treatments to Patients with the Right CDMO Outsourcing Model

Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children

THE GLOCALISATION CLASSROOM

Astute glocalisers learn from their successes and failures

In the first article in this series The Glocalisation Challenge I differentiated between astute and nave glocalisers and in this fourth and final article

Revolutionising Pharma

Six game-changing ways to excel with integrated quality solution

The pharmaceutical industry is known for its complexity and strict regulations making it challenging for companies to maintain highquality standards while still remaining competitiveThe pharmaceutical industry is known for its complexity and strict regulations making it challenging for companies to maintain highquality standards while still remaini...

Pharmaceutical Business Strategy and Forecasting

Creating insights from market research

The pharma sectors ongoing transformation has prompted most pharma and biotech players to focus on launching new products developing innovative technologies virtual clinical trials and rapid digitalisation These initiatives are proving to be quite challenging

Revolutionising the Pharma Supply Chain

Blockchain, Digitalisation, and Collaboration

The continuous digital transformation including blockchain technology for greater traceability increasing attention to sustainability and a move towards

Real-world Evidence

How patient-led insights are transforming the way we develop health policy

Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA

The Glocalisation Change

Your second important glocalisation decision is how to adapt to local conditions

The first article in this series began from the premise that exploiting global markets creates a dilemma for pharmaceutical and other life sciences companies which I called the glocalisation challenge

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference